Literature DB >> 14519723

Interferon alpha treatment and endocrine disease.

Wing Bun Chan1, Chun Chung Chow, Clive Stewart Cockram.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14519723      PMCID： PMC544626          DOI： 10.1177/014107680309601003

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  49 in total

1.  Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection.

Authors:  C Betterle; P Fabris; R Zanchetta; B Pedini; G Tositti; E Bosi; F de Lalla
Journal:  Diabetes Care       Date:  2000-08       Impact factor: 19.112

2.  Virologic factors related to interferon-alpha-induced thyroid dysfunction in patients with chronic hepatitis C.

Authors:  M C Hsieh; M L Yu; W L Chuang; S J Shin; C Y Dai; S C Chen; Z Y Lin; M Y Hsieh; J F Liu; L Y Wang; W Y Chang
Journal:  Eur J Endocrinol       Date:  2000-05       Impact factor: 6.664

3.  The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism.

Authors:  Carlo Carella; Gherardo Mazziotti; Filomena Morisco; Mario Rotondi; Michele Cioffi; Concetta Tuccillo; Francesca Sorvillo; Nicola Caporaso; Giovanni Amato
Journal:  Eur J Endocrinol       Date:  2002-06       Impact factor: 6.664

4.  Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy.

Authors:  O Dalgard; K Bjøro; K Hellum; B Myrvang; T Bjøro; E Haug; H Bell
Journal:  J Intern Med       Date:  2002-05       Impact factor: 8.989

5.  Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice.

Authors:  K Kawai; T Enomoto; V Fornasier; E Resetkova; R Volpé
Journal:  Proc Assoc Am Physicians       Date:  1997-03

6.  Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C.

Authors:  P Cacoub; C Renou; E Rosenthal; P Cohen; I Loury; V Loustaud-Ratti; A M Yamamoto; A C Camproux; P Hausfater; L Musset; P Veyssier; G Raguin; J C Piette
Journal:  Medicine (Baltimore)       Date:  2000-01       Impact factor: 1.889

7.  Liver and thyroid function and autoimmunity during interferon-beta 1b treatment for MS.

Authors:  L Durelli; B Ferrero; A Oggero; E Verdun; A Ghezzi; E Montanari; M Zaffaroni
Journal:  Neurology       Date:  2001-10-23       Impact factor: 9.910

8.  Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis C virus infection.

Authors:  A Rocco; S Gargano; A Provenzano; M Nardone; G M De Sanctis; N Altavilla; L V Chircu; F Grimaldi
Journal:  Neuro Endocrinol Lett       Date:  2001       Impact factor: 0.765

9.  Long-term outcome of interferon-alpha-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment.

Authors:  C Carella; G Mazziotti; F Morisco; G Manganella; M Rotondi; C Tuccillo; F Sorvillo; N Caporaso; G Amato
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

10.  Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C.

Authors:  B Wesche; E Jaeckel; C Trautwein; H Wedemeyer; A Falorni; H Frank; A von zur Mühlen; M P Manns; G Brabant
Journal:  Gut       Date:  2001-03       Impact factor: 23.059
View more
  4 in total

1.  Autoantibodies and autoimmune disease during treatment of children with chronic hepatitis C.

Authors:  Jean P Molleston; William Mellman; Michael R Narkewicz; William F Balistreri; Regino P Gonzalez-Peralta; Maureen M Jonas; Steven J Lobritto; Parvathi Mohan; Karen F Murray; Dolores Njoku; Philip Rosenthal; Bruce A Barton; Monica V Talor; Irene Cheng; Kathleen B Schwarz; Barbara A Haber
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-03       Impact factor: 2.839

Review 2.  Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis.

Authors:  Takashi Himoto; Mikio Nishioka
Journal:  Auto Immun Highlights       Date:  2013-02-22

Review 3.  Extrahepatic manifestations and autoantibodies in patients with hepatitis C virus infection.

Authors:  Takashi Himoto; Tsutomu Masaki
Journal:  Clin Dev Immunol       Date:  2012-09-05

Review 4.  Frequency of thyroid dysfunctions during interferon alpha treatment of single and combination therapy in hepatitis C virus-infected patients: a systematic review based analysis.

Authors:  Chandrasekharan Nair Kesavachandran; Frank Haamann; Albert Nienhaus
Journal:  PLoS One       Date:  2013-02-01       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.